Your browser doesn't support javascript.
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature.
Pala, Laura; Conforti, Fabio; Cocorocchio, Emilia; Ferrucci, Pierfrancesco; De Pas, Martino Tommaso; Stucchi, Sara; Repetto, Matteo; Saponara, Maristella; Queirolo, Paola.
  • Pala L; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Conforti F; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Cocorocchio E; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Ferrucci P; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • De Pas MT; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Stucchi S; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Repetto M; Research Nurses Team, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Saponara M; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Queirolo P; Department of Oncology and Haematology, University of Milan, Milan, Italy.
Cancer Invest ; 39(1): 9-14, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-894477
ABSTRACT
The outbreak of COVID-19 pandemia is a major health worldwide concern. Patients with cancer might have a worse outcome, because of the immunosuppression determined by the tumor itself and anti-cancer treatments, including chemotherapy and radiotherapy. The impact and course of viral infection in patients receiving immunotherapy remains unknown. We report the case of a patient with metastatic melanoma, long responder to anti PD-1 blockade who got infected with Sars CoV-2, recovering without sequelae. A critical review of literature was performed. Limited data available in literature support the possibility to continue the immunotherapy in patients with cancer under control.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / SARS-CoV-2 / COVID-19 / Melanoma Type of study: Case report / Observational study / Prognostic study / Reviews Topics: Long Covid Limits: Humans / Male / Middle aged Language: English Journal: Cancer Invest Year: 2021 Document Type: Article Affiliation country: 07357907.2020.1844893

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / SARS-CoV-2 / COVID-19 / Melanoma Type of study: Case report / Observational study / Prognostic study / Reviews Topics: Long Covid Limits: Humans / Male / Middle aged Language: English Journal: Cancer Invest Year: 2021 Document Type: Article Affiliation country: 07357907.2020.1844893